Comments

Response to Comment on: Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Oct 9, 2025 https://doi.org/10.3324/haematol.2025.289205